Unique ID issued by UMIN | UMIN000048995 |
---|---|
Receipt number | R000055814 |
Scientific Title | A study to evaluate the effect of food ingredient in healthy adult on the blood glucose level -Open label, single intake crossover comparative method- |
Date of disclosure of the study information | 2022/09/23 |
Last modified on | 2022/09/22 11:58:30 |
A study to evaluate the effect of food ingredient in healthy adult on the blood glucose level -Open label, single intake crossover comparative method-
A study to evaluate the effect of food ingredient in healthy adult on the blood glucose level
A study to evaluate the effect of food ingredient in healthy adult on the blood glucose level -Open label, single intake crossover comparative method-
A study to evaluate the effect of food ingredient in healthy adult on the blood glucose level
Japan |
Healthy adult
Adult |
Others
NO
To evaluate the effect of single intake of test foods on blood glucose level placebo as a control
Efficacy
Blood glucose level
Insulin level, Glucose dependent insulinotropic polypeptide level, and Glucagon Like Peptide-1 level
Interventional
Cross-over
Randomized
Cluster
Open -no one is blinded
Placebo
3
Prevention
Food |
Ingestion of test foods (research foods 1)
Ingestion of test foods (research foods 2)
Ingestion of placebo
20 | years-old | <= |
75 | years-old | >= |
Male and Female
(1) Japanese males between 20 and 75 years of age.
(2) Subjects who voluntarily wish to participate in the clinical trial and provide written consent.
(3) Subjects who able to maintain a consistent daily lifestyle during the study period.
(1) Subjects with serious diseases (diabetes, heart disease, cancer, etc.) or mental illness.
(2) Subjects with a history of serious diseases (diabetes, heart disease, liver disease, renal disease, cancer, etc.) in the past.
(3) Subjects who have donated more than 200mL of blood in the past month or 400mL within the past 3 months.
(4) Subjects who have experienced illness or deterioration of physical condition due to blood collection in the past.
(5) Subjects who have symptoms of severe anemia.
(6) Subjects who are unable to maintain their daily lifestyle due to significant changes in diet and physical activity.
(7) Subjects with possible food or drug allergies to the test foods.
(8) Subjects who consume food for specified health use, health food, etc. on a daily basis.
(9) Subjects who are otherwise ineligible for participation in this study by the investigater.
15
1st name | Ryosuke |
Middle name | |
Last name | Mastuoka |
Kewpie Corporation
R&D Division
182-0002
2-5-7, Sengawa-cho, Chofu-shi, Tokyo
03-5384-7759
ryosuke_mastuoka@kewpie.co.jp
1st name | Tomomi |
Middle name | |
Last name | Tanaka |
Kewpie Corporation
R&D Division
182-0002
2-5-7, Sengawa-cho, Chofu-shi, Tokyo
03-5384-7759
tomomi_tanaka@kewpie.co.jp
Kewpie Corporation
Kewpie Corporation
Profit organization
CX Wellness Co., Ltd
Ueno-Asagao Clinic Ethical Review Committee
6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN
03-6240-1162
info@ueno-asagao.clinic
NO
2022 | Year | 09 | Month | 23 | Day |
Unpublished
16
No longer recruiting
2022 | Year | 09 | Month | 07 | Day |
2022 | Year | 09 | Month | 07 | Day |
2022 | Year | 09 | Month | 24 | Day |
2022 | Year | 11 | Month | 30 | Day |
2022 | Year | 09 | Month | 22 | Day |
2022 | Year | 09 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055814
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |